Efficacy and Safety of Rituximab in the Management of Pediatric Systemic Lupus Erythematosus: A Systematic Review-Reference-Cited by-同舟云学术

Efficacy and Safety of Rituximab in the Management of Pediatric Systemic Lupus Erythematosus: A Systematic Review

Published:2017-08 Issue: Volume:187 Page:213-219.e2
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Mahmoud Ines,Jellouli Manel,Boukhris Imen,Charfi Rim,Ben Tekaya Aicha,Saidane Olfa,Ferjani Maryem,Hammi Yousra,Trabelsi Sameh,Khalfallah Narjess,Tekaya Rawdha,Gargah Tahar,Abdelmoula Leila

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference37 articles.

1. Prevalence and burden of pediatric-onset systemic lupus erythematosus;Kamphuis;Nat Rev Rheumatol,2010

2. Children and adolescents with SLE: not just little adults;Morgan;Lupus,2013

3. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII);Tucker;Lupus,2008

4. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases;El-Hallak;J Pediatr,2007

5. Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus;Hui-Yuen;Lupus,2016

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic lupus erythematosus with juvenile onset: current status of the problem (literature review);Modern Rheumatology Journal;2024-04-22

2. BCD020 rituximab bioanalog compared to standard treatment in juvenile systemic lupus erythematosus: The data of 12 months case-control study;World Journal of Clinical Pediatrics;2024-03-09

3. Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score;Lupus;2024-02-05

4. Rituximab alleviates pediatric systemic lupus erythematosus associated refractory immune thrombocytopenia: a case-based review;Immunologic Research;2024-01-27

5. Rituximab as an effective add-on maintenance therapy for disease activities in childhood-onset systemic lupus erythematosus;Lupus Science & Medicine;2024-01